Antagonistic interaction between Nodal and insulin modulates pancreatic β-cell proliferation and survival

Cell Commun Signal. 2018 Nov 8;16(1):79. doi: 10.1186/s12964-018-0288-0.

Abstract

Background: Insulin signaling pathway in β-cell is essential to promote β-cells proliferation and survival, while Nodal-ALK7-Smad3 signaling involves β-cells apoptosis. We attempted to address inter-relationship between Nodal and insulin in modulating β-cell proliferation and apoptosis.

Methods: Using INS-1 β-cells and isolated rat islets, we examined the effects of Nodal, insulin, or the two combined on β-cell proliferation and/or apoptosis.

Results: The β-cells under high-glucose or palmitate conditions showed significant up-regulation of Nodal expression and activation of its downstream signaling pathway resulted in increased cleaved caspase-3. Insulin treatment led to significantly attenuated Nodal-induced cell apoptotic pathway. Similar results were found in directly Nodal-treated β-cell that insulin could partially block Nodal-induced up-regulation of ALK7-Smad3-caspase-3 signaling pathways with significantly attenuated β-cell apoptosis. Interestingly, we found that insulin-induced Akt activation and downstream molecules including GSK-3β, β-catenin and ERK1/2 was significantly attenuated by the co-treatment with Nodal, resulted in decreased cell proliferation. Furthermore, Nodal decreased glucose-evoked calcium influx and played a negative role during glucose-stimulated insulin secretion in the β-cells. Immunocytochemistry studies showed that Nodal treatment translocated Smad3 from cytosol mostly to the nucleus; however, co-treatment with insulin significantly decreased Smad3 nuclear localization. Co-immunoprecipitation experiments showed a directly interaction between Smad3 and Akt, and this interaction was enhanced by co-treatment with insulin.

Conclusions: Our data suggest that the antagonistic interaction between Nodal and insulin has a role in the regulation of β-cell mass and secretion.

Keywords: Autocrine; Diabetes; Insulin; Nodal; β-Cell.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Active Transport, Cell Nucleus / drug effects
  • Activin Receptors, Type I / metabolism
  • Animals
  • Apoptosis / drug effects
  • Cell Nucleus / drug effects
  • Cell Nucleus / metabolism
  • Cell Proliferation / drug effects
  • Cell Survival / drug effects
  • Dose-Response Relationship, Drug
  • Down-Regulation / drug effects
  • Drug Interactions
  • Gene Expression Regulation / drug effects
  • Glucose / pharmacology
  • Glycogen Synthase Kinase 3 beta / metabolism
  • Humans
  • Insulin / pharmacology*
  • Insulin-Secreting Cells / cytology*
  • Insulin-Secreting Cells / drug effects*
  • Insulin-Secreting Cells / metabolism
  • Male
  • Mice
  • Mitogen-Activated Protein Kinase 1 / metabolism
  • Mitogen-Activated Protein Kinase 3 / metabolism
  • Nodal Protein / pharmacology*
  • Palmitic Acid / pharmacology
  • Phosphorylation / drug effects
  • Rats
  • Rats, Sprague-Dawley
  • Smad3 Protein / metabolism
  • beta Catenin / metabolism

Substances

  • Insulin
  • Nodal Protein
  • Smad3 Protein
  • beta Catenin
  • Palmitic Acid
  • Glycogen Synthase Kinase 3 beta
  • Mitogen-Activated Protein Kinase 1
  • Mitogen-Activated Protein Kinase 3
  • Activin Receptors, Type I
  • Acvr1c protein, rat
  • Glucose